(Q28729059)

Pascaline Boudou-Rouquette

inferred from title

author

5

object named as

Pascaline Boudou-Rouquette

Pascaline

Boudou-Rouquette

1 reference

8 April 2024

9

Stanislas Pol

Stanislas

Pol

1 reference

8 April 2024

0 references

Michel Vidal

8

Michel

Vidal

2 references

ORCID Public Data File 2021

8 April 2024

2

Romain Coriat

Romain

Coriat

1 reference

8 April 2024

Olivier Mir

1

0 references

Benoit Blanchet

3

Benoit

Blanchet

1 reference

8 April 2024

Jean-Philippe Durand

4

Jean-Philippe

Durand

1 reference

8 April 2024

Judith Michels

6

Judith

Michels

1 reference

8 April 2024

Stanislas Ropert

7

Stanislas

Ropert

1 reference

8 April 2024

Stanislas Chaussade

10

Stanislas

Chaussade

1 reference

8 April 2024

François Goldwasser

11

François

Creative Commons Attribution 4.0 International

Goldwasser

1 reference

8 April 2024

language of work or name

English

0 references

publication date

2012

0 references

published in

PLOS One

0 references

volume

7

0 references

issue

5

0 references

page(s)

e37563

0 references

copyright license

start time

30 May 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

ImageJ

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3364283/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364283

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364283

Sorafenib in advanced hepatocellular carcinoma

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364283

17 March 2017

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364283

Definition and classification of cancer cachexia: an international consensus

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364283

Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364283

Management of hypertension in angiogenesis inhibitor-treated patients

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364283

Inflammation and CYP3A4-mediated drug metabolism in advanced cancer: impact and implications for chemotherapeutic drug dosing

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364283

Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364283

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364283

Human body composition: advances in models and methods

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3364283

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

3 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037563

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037563

Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037563

An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037563

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037563

Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037563

Sarcopenia is predictive of nosocomial infection in care of the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037563

Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0037563

Saturable absorption of sorafenib in patients with solid tumors: a population model

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22666367

12 December 2020

inferred from PubMed ID database lookup

Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22666367

12 December 2020

inferred from PubMed ID database lookup

Sorafenib dose escalation in the treatment of advanced hepatocellular carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22666367

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1371/JOURNAL.PONE.0037563

1 reference

2356671

ADS bibcode

2012PLoSO...737563M

0 references

2356671

1 reference

1 reference

1 reference